癌症研究
综合应力响应
压力(语言学)
战斗或逃跑反应
医学
肺癌
生物
翻译(生物学)
肿瘤科
信使核糖核酸
生物化学
基因
哲学
语言学
作者
Shruthy Suresh,Beibei Chen,Jingfei Zhu,Ryan Golden,Changzheng Lu,Bret M. Evers,Nicole Novaresi,Bethany Smith,Xiaowei Zhan,Vanessa Schmid,Sojeong Jun,Chelsea M. Karacz,Michael Peyton,Lin Zhong,Zhuoyu Wen,Adwait Amod Sathe,Chao Xing,Carmen Behrens,Ignacio I. Wistuba,Guanghua Xiao
出处
期刊:Nature cancer
[Nature Portfolio]
日期:2020-04-20
卷期号:1 (5): 533-545
被引量:123
标识
DOI:10.1038/s43018-020-0056-0
摘要
Cancer cells express high levels of programmed death ligand 1 (PD-L1), a ligand of the programmed cell death protein 1 (PD-1) receptor on T cells, allowing tumors to suppress T cell activity. Clinical trials utilizing antibodies that disrupt the PD-1/PD-L1 checkpoint have yielded remarkable results, with anti-PD-1 immunotherapy approved as a first-line therapy for patients with lung cancer. We used CRISPR-based screening to identify regulators of PD-L1 in human lung cancer cells, revealing potent induction of PD-L1 upon disruption of heme biosynthesis. Impairment of heme production activates the integrated stress response, allowing bypass of inhibitory upstream open reading frames in the PD-L1 5′ untranslated region, resulting in enhanced PD-L1 translation and suppression of anti-tumor immunity. We demonstrate that integrated stress-response-dependent PD-L1 translation requires the translation initiation factor eIF5B. eIF5B overexpression, which is frequent in lung adenocarcinomas and associated with poor prognosis, is sufficient to induce PD-L1. These findings illuminate mechanisms of immune checkpoint activation and identify targets for therapeutic intervention. O'Donnell and colleagues report that activation of the integrated stress response in non-small cell lung cancer cells by impairing heme production leads to enhanced PD-L1 translation in an eIF5B-dependent manner.
科研通智能强力驱动
Strongly Powered by AbleSci AI